Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 | P22748 | 2/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
| ▸ | LTA4H | P09960 | 3/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.34 |
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3482552 | 0.88 | ACHE (0.43) | CA4KMT2ATSHRSMN1; SMN2LMNA | |
| SCHEMBL27757762 | 0.84 | LTA4H (0.56) | CA4CA1CA2LTA4HKMT2A | |
| SCHEMBL19784955 | 0.81 | LTA4H (0.58) | CA4CA1CA2LTA4HKMT2A | |
| SCHEMBL28753767 | 0.79 | ACHE (0.36) | CA4CA1CA2CA7CA9 | |
| SCHEMBL3795354 | 0.78 | CA4 (0.38) | CA4CA12CA1CA2CA7 | |
| SCHEMBL202617 | 0.77 | CA4 (0.41) | CA4CA12CA1CA2CA7 | |
| SCHEMBL308706 | 0.75 | TSHR (0.35) | CA4CA12CA1CA2CA7 | |
| Ammonia Solution, Strong SCHEMBL28286688 | 0.74 | CA4 (0.39) | CA4CA12CA1CA2CA7 | |
| SCHEMBL288583 | 0.74 | CA4 (0.39) | CA4CA12CA1CA2CA7 | |
| Benzene SCHEMBL27757751 | 0.74 | CA4 (0.39) | CA4CA12CA1CA2CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 522 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250329799-A1 | SYSTEM AND METHOD FOR IMPROVED BATTERY SAFETY | Anthro Energy, Inc. (US) | 2025-10-23 | — | — | US | claimed |
| CN-118290922-A | High-strength high-toughness PC/PBT alloy plastic and preparation method thereof | 上海祺申塑业股份有限公司 | 2024-07-05 | — | — | CN | claimed |
| CN-115181223-B | Low-gloss matte auxiliary agent, preparation method thereof and molded body | 铨盛聚碳科技股份有限公司 | 2023-08-29 | — | — | CN | claimed |
| CN-115386087-A | Hydrosilylation self-crosslinking self-chain-extension linear polysiloxane and preparation method thereof | 广东粤港澳大湾区黄埔材料研究院 | 2022-11-25 | — | — | CN | claimed |
| US-20200332149-A1 | ORGANOFUNCTIONAL SILOXANES, PROCESS FOR PREPARING SAME AND THEIR USE FOR THE TREATMENT OF FILLINGS AND SURFACES | ABCR LABORATORIOS, S.L. (ES) | 2020-10-22 | — | — | US | claimed |
| EP-3543304-A1 | ORGANOFUNCTIONAL SILOXANES, METHOD FOR ITS PREPARATION AND USE FOR THE TREATMENT OF FILLERS AND SURFACES | ABCR Laboratorios, S.L. (ES) | 2019-09-25 | — | — | EP | claimed |
| US-20100137525-A1 | Catalyst composition for hydrogenation and their use for hydrogenation conjugated diene polymer | CHI-MEI CORPORATION | 2010-06-03 | — | — | US | claimed |
| US-20080171653-A1 | Catalyst composition for hydrogenation and their use for hydrogenation conjugated diene polymer | CHI-MEI CORPORATION | 2008-07-17 | — | — | US | claimed |
| US-20070282121-A1 | INTERMEDIATES FOR THE SYNTHESIS OF POLYPROPIONATE ANTIBIOTICS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2007-12-06 | — | — | US | claimed |
| US-7297807-B1 | Intermediates for the synthesis of polypropionate antibiotics | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 2007-11-20 | — | — | US | claimed |
| US-20020037980-A1 | Method for producing ethylene homo- and co-polymer | SAMSUNG GENERAL CHEMICALS CO., LTD. (KR) | 2002-03-28 | — | — | US | claimed |
| US-20020012850-A1 | Silane compounds as additive in electrolytes for electrochemical cells | MERCK PATENTGESELLSCHAFT (DE) | 2002-01-31 | — | — | US | claimed |
| CN-1328355-A | Silane compound used as additives of electrochemical accumulator electrolyte | MERCK PATENT GMBH (DE) | 2001-12-26 | — | — | CN | claimed |
| EP-1162682-A1 | Silane compounds as additives in electrolytes of electrochemical cells | MERCK PATENT GmbH (DE) | 2001-12-12 | — | — | EP | claimed |
| WO-2001092345-A1 | A METHOD FOR PRODUCING ETHYLENE HOMO- AND CO-POLYMER | SAMSUNG GENERAL CHEMICALS CO., LTD. (KR) | 2001-12-06 | — | — | WO | claimed |
| US-6313230-B1 | HYDROGENATING CONJUGATED DIENE POLYMERS IN PRESENCE OF HYDROGEN AND A HYDROGENATION CATALYST FORMULATION COMPRISING TITANIUM COMPOUND, SILYL HYDRIDE COMPOUND, POLYSILOXANE, SILAZAN COMPOUND, AND METALLIC COMPOUND | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2001-11-06 | — | — | US | claimed |
| EP-0990014-B1 | PIGMENTED POROUS MATERIAL | CIBA SC HOLDING AG (CH) | 2001-08-29 | — | — | EP | claimed |
| US-20010012559-A1 | Colored porous material such as leather, imitation leather, chalk, wood, and concrete having organic pigment in its pores obtainable by fragmenting a meltable or solvent soluble pigment precursor | CIBA SPECIALTY CHEMICALS CORP | 2001-08-09 | — | — | US | claimed |
| EP-0990014-A1 | PIGMENTED POROUS MATERIAL | Ciba SC Holding AG (CH) | 2000-04-05 | — | — | EP | claimed |
| WO-1998058027-A1 | PIGMENTED POROUS MATERIAL | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 1998-12-23 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070282121-A1 | INTERMEDIATES FOR THE SYNTHESIS OF POLYPROPIONATE ANTIBIOTICS | DHPS, EMG1, RPN1 | CA4 4411/4885CA12 4749/4885CA1 4880/4885 |
| US-20200332149-A1 | ORGANOFUNCTIONAL SILOXANES, PROCESS FOR PREPARING SAME AND THEIR USE FOR THE TREATMENT OF FILLINGS AND SURFACES | FDFT1, DBF4, IPO4 | CA4 809/4885CA12 3190/4885CA1 1238/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.